2018

The 1st European Day GRIN2B brings together families suffering from this rare illness in Barcelona

Sant Joan de Déu Hospital hosts the event, through which parents will get to know the GRIN2B research team in Barcelona led by Dr. Xavier Altafaj, IDIBELL researcher

The 1st European Day GRIN2B brings together families suffering from this rare illness in Barcelona Read More »

Dr. Manel Esteller, awarded by the ECO Foundation for Excellence and Quality of Oncology

Manel Esteller, director of the epigenetics and cancer biology program at IDIBELL, ICREA researcher and professor at the University of Barcelona, has received the Award of the ECO Foundation for Excellence and Quality in Oncology, awarded last Saturday 22nd at the Spanish Royal Academy of Medicine, in Madrid.   The foundation has distinguished Dr. Esteller

Dr. Manel Esteller, awarded by the ECO Foundation for Excellence and Quality of Oncology Read More »

ONCE and the Bellvitge Biomedical Research Institute (IDIBELL) renew their collaboration to study hereditary dystrophies of the retina

These dystrophies are disorders with great clinical and genetic heterogeneity for which there is no cure today; 15,000 people in Spain suffer from them

ONCE and the Bellvitge Biomedical Research Institute (IDIBELL) renew their collaboration to study hereditary dystrophies of the retina Read More »

IDIBELL participates in the COST BESTPRAC meeting held in Belgrade, Serbia

The 10th BESTPRAC Working Group meeting was held from September 24-25 at the Faculty of Electrical Engineering, University of Belgrade, Serbia and gathered over 100 people from different European countries. IDIBELL attended the meeting as part of the action plan to boost its internationalization. COST BESTPRAC is one of the most relevant networks of research

IDIBELL participates in the COST BESTPRAC meeting held in Belgrade, Serbia Read More »

IDIBELL researchers receive AECC grants on World Cancer Research Day

On the occasion of World Cancer Research Day (WCRD), which takes place every year on September 24th, the Spanish Association Against Cancer (AECC) awarded its 2018 AECC Cancer Research grants. The awards ceremony was chaired by Her Majesty the Queen, as Honorary President of the AECC and the AECC Scientific Foundation. This year, AECC has

IDIBELL researchers receive AECC grants on World Cancer Research Day Read More »

A new epigenetic signature predicts the response to immunotherapy in lung cancer

An article published in The Lancet Respiratory Medicine by Dr. Manel Esteller, Director of the Epigenetics and Cancer Biology Program (PEBC) of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Researcher and Professor of Genetics at the University of Barcelona, proves that a specific pattern of epigenetic alterations in lung cancer predictss whether the tumor will

A new epigenetic signature predicts the response to immunotherapy in lung cancer Read More »

Scroll to Top